Login / Signup

Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study.

Paul GlueShona NeehoffAmandine SabadelLucy BroughtonMartin Le NedelecShabah ShadliNeil McNaughtonNatalie J Medlicott
Published in: Journal of psychopharmacology (Oxford, England) (2019)
Ketamine may be a potential therapeutic option for patients with treatment-resistant generalized anxiety and social anxiety disorders.
Keyphrases
  • healthcare
  • mental health
  • double blind
  • pain management
  • sleep quality
  • clinical trial
  • randomized controlled trial
  • placebo controlled
  • combination therapy
  • study protocol
  • phase ii
  • smoking cessation